AZN vs FNB · P/E 28, $288.38B cap vs P/E 12, rev $1.15B
AstraZeneca PLC (AZN) versus F.N.B. Corp (FNB) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
F.N.B. Corp (FNB) is a banks - regional company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported FNB revenue for 2026-06-30 was $1.15B. Net income was $286.0M. FNB currently screens at market cap $5.67B and trailing P/E 12.2.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. FNB currently screens at market cap $5.67B and trailing P/E 12.2.
Not investment advice. Open the AZN and FNB stock pages for the full models.
Not investment advice.